Latest International AIDS Vaccine Initiative Stories
ATLANTA, Aug. 27 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc.
ROCKVILLE, Md., Aug. 17 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the IMVAC Summit. The Conference will take place August 17-19, 2010 at the Royal Sonesta Hotel, Cambridge, MA. Dr.
Black Treatment Advocates Network (BTAN) Focuses on Improving Care for Thousands of Black Americans in the U.S. WHITEHOUSE STATION, N.J. and LOS ANGELES, Calif., Aug.
ATLANTA, Aug. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announces that Chief Executive Officer Dr.
SMYRNA, Ga., July 22 /PRNewswire-FirstCall/ -- Dr. Harriet L. Robinson, Chief Scientific Officer at GeoVax Labs, Inc.
VIENNA, July 20 /PRNewswire-USNewswire/ -- Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today warns that flat funding for HIV prevention research may limit researchers' ability to quickly move promising approaches forward.
In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031 VIENNA, July 19 /PRNewswire-USNewswire/ -- Speaking to the 18th International AIDS Conference today, Bill Gates called on all countries to keep up the fight against HIV/AIDS, saying the world has an historic opportunity to "change the face of AIDS." Mr.
SMYRNA, Ga., July 2 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc.
The findings advance the effort to develop an AIDS vaccine.
ATLANTA, May 27 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc.
- A woman chauffeur.
- A woman who operates an automobile.